3187 results for «9245»
3187 results
Rotational atherectomy for the treatment of calcified coronary lesion - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Let's see how this 80-year-old female patient with hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, history of ischaemic heart disease (2018) and NSTEMI (August 2022), currently asymptomatic but mainly homebound, was treated LIVE, and learn more about the treatment of calcified coronary lesion.
DCB in variable day-to-day clinical scenarios
07 Oct 2022 – From AICT-AsiaPCR 2022
In this AICT AsiaPCR 2022 session 4 cases will be discussed that will enable you to learn more about drug-coated balloons and the variable indications for their use in daily practice, or techniques for using them in different lesion settings.
Treatment of calcified lesions
07 Oct 2022 – From AICT-AsiaPCR 2022
Consider a 66-year-old man, hypertensive and diabetic for 10 years, with history of recurrent substernal chest pain and exertional dyspnea, who presented with easy fatigability and shortness of breath, or a 72-year-old man on dialysis who presented with STEMI and severe calcified stenosis of LAD/DI bifurcation,...
Treatment of severe tricuspid regurgitation - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Watch the LIVE case management of an 84-year-old male patient, diabetic, hypertensive, with previous PCI on LAD and ICD, permanent AF, and exertional dyspnea for 6 months and learn more about severe tricuspid regurgitation pathology and treatment.
The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms
18 May 2022 – From EuroPCR 2022
Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...
How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology
18 May 2022 – From EuroPCR 2022
What is angiographic SYNTAX score? Are 3VD all the same? What do ESC guidelines recommend? You will find answers to these questions, and many more, in this EuroPCR 2022 session, through which you will learn how to identify the right patient for three-vessel PCI, select the lesions to be...
The challenge of the diabetic patient with diffuse coronary artery disease: how physiology can simplify things
18 May 2022 – From EuroPCR 2022
Based on the didactic analysis of several practical cases, and also on the latest guidelines and study outcomes on the subject, learn in this EuroPCR 2022 session new management strategies to optimise PCI in diffuse coronary artery disease, new developments of the Optowire to support decision-making in patients...
Angiography-derived physiological assessment of coronary artery stenosis severity and microvascular dysfunctions
18 May 2022 – From EuroPCR 2022
Follow the demonstrations of this EuroPCR 2022 session to understand the principles, clinical value, and applicability of coronary angiography-derived fractional flow reserve (caFFR), to discuss coronary angiography-derived index of microcirculatory resistance (caIMR) in the assessment of epicardial stenosis and coronary microcirculation, and to review data from available trials supporting these new...
From access to closure in transcatheter valve procedures - Optimising patients' outcomes step by step
18 May 2022 – From EUROPCR 2022
Watch this EuroPCR 2022 session to learn the key steps in transcatheter mitral valve repair and transcatheter aortic valve implantation procedures.
Follow step by step how to optimally access and close venous large bore access sites using suture mediated vessel closure devices, and learn about the key...
Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent, and VitaFlow valve
18 May 2022 – From EuroPCR 2022
The objective of this EuroPCR 2022 session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China,...
Pressure microcatheter guided PCI: to optimise stent implantation and to safely assess the functional result
18 May 2022 – From EuroPCR 2022
Through the case study of a 71-year-old female patient with hypertension, dyslipidemia, previous TIA, and stress-induced chest pain, among other things, this EuroPCR 2022 session will allow you to understand the major role of longitudinal functional evaluation of CAD, learn tips and tricks in using pressure microcatheter in PCI...
The current role of paclitaxel DCB in PCI
18 May 2022 – From EuroPCR 2022
Thanks to the different interventions of this EuroPCR 2022 session, understand the role of paclitaxel DCB in modern era interventional cardiology, the differences, and advantages versus DES, the role of blended therapies in CLS, and learn how to correctly prepare the lesion and obtain the best from this technology on...
Looking at the heart and the brain - What is the role of LAA closure?
18 May 2022 – From EuroPCR 2022
Based on a pre-registered case study of a 68-year-old male patient, DG, who presented with atrial fibrillation, intracranial bleeding on warfarin, and compartment syndrome secondary to bleeding from warfarin, this EuroPCR 2022 session will allow you to discuss the challenges of treating AF patients with previous intracranial...
The role of coronary interventionalist in TAVI - From referral to timing of PCI
19 May 2022 – From EuroPCR 2022
Consult this session to learn how to contribute to streamlined pre- and post-TAVI patient pathways, to discover updates on the optimised TAVI procedure and appreciate the variances in different valve designs and the long-term patient outcomes, as well as to discuss the right time of PCI in TAVI patients...
Imaging in LAA occlusion: from planning to final assessment
19 May 2022 – From EuroPCR 2022
Consult this session to learn about imaging supporting LAA occlusion procedure, how to combine different imaging techniques to guide this intervention and their value for procedure planning.
The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI
19 May 2022 – From EuroPCR 2022
Consult this session to learn more about the characteristics of atrial fibrillation patients undergoing TAVI, the priority of stroke prevention in atrial fibrillation patients post-TAVI, as well as the current understanding in Japanese and Asian patients.
A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation
19 May 2022 – From EuroPCR 2022
In this session from EuroPCR 2022, the speakers introduce different options available for treating tricuspid regurgitation. They discuss the anatomical considerations that define suitable candidates and review different transcatheter options and their key differentiators.
What's next in DES technology? Innovative DES platforms combining DES with DCB
19 May 2022 – From EUROPCR 2022
Via a series of case presentations, learn more about the dual drug delivery from DES and DCB platform to treat diabetes mellitus patients. Understand its efficiency in a complex setting and see how a no-polymer DES and DCB platform can fill the gaps of the unmet...
EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.
